Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 19Prostatic Neoplasms 9Polycystic Ovary Syndrome 7Vitamin D Deficiency 6Osteoporosis 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 4Colonic Neoplasms 4Obesity 3Inflammation 3Colorectal Neoplasms 3Bone Diseases, Metabolic 3Neoplasm Metastasis 2Multiple Endocrine Neoplasia Type 1 2Motor Activity 2Lymphoma 2Lung Neoplasms 2Leukemia 2Gastrointestinal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Warts 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Solid Cancers 1

Interventions

teriflunomide 1Vitamin D 1Natalizumab 1Fingolimod Hydrochloride 1Dimethyl Fumarate 1Cholecalciferol 1Calcifediol 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multiple Sclerosis, Relapsing-Remitting × Vitamin D × Clear all
NCT05340985 2022-04-22

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Tehran University of Medical Sciences

Phase 4 Unknown
54 enrolled
LymphoidOther hematologic neoplasm

Multiple Sclerosis, Relapsing-Remitting, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡